From: Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma
Formulations
Concentration of SFN (nM)
Concentration of TPL (nM)
CI50
SFN@CPLCNPs
2350.93
TPL@CPLCNPs
8.91
(SFN + TPL)@LCNPs
22.49
2.25
0.26
(SFN + TPL)@PLCNPs
12.03
1.20
0.14
(SFN + TPL)@CLCNPs
7.61
0.76
0.09
(SFN + TPL)@CPLCNPs
5.44
0.54
0.06